Ropes & Gray represented Sanofi in the transaction, and Wilson Sonsini Goodrich & Rosati represented Ventyx Biosciences, Inc. Sanofi announced a $27 million strategic investment in...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Cardinal Health in the transaction. Cardinal Health (NYSE: CAH) announced it has entered into an agreement to acquire Integrated Oncology Network (ION),...
You must be a Standard 1 Year member to access this content.
Dechert represented Apollo Debt Solutions BDC in the offering, and Ropes & Gray represented the initial purchasers. Apollo Debt Solutions (“ADS”) (NYSE: APO) announced an offering...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genstar Capital in the transaction, and McDermott Will & Emery represented Flourish Research. Flourish Research (“Flourish” or the “Company”) announced a strategic...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented SK Biopharmaceuticals on the transaction. SK Biopharmaceuticals announced it has entered into an global licensing agreement with radiotherapy company Full-Life Technologies (“Full-Life”)...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
You must be a Standard 1 Year member to access this content.
Milbank advised Viking Holdings Ltd on the offering, Latham & Watkins advised the underwriters and Ropes & Gray advised the selling shareholders. Viking Holdings Ltd (NYSE:...
You must be a Standard 1 Year member to access this content.
Walter Billet Avocats advised Akur8 on its fundraising. Goodwin assisted One Peak. Ropes & Gray represented Partners Group. Akur8 secured $120 million in a series C...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Kohlberg & Company on the deal. Kohlberg & Company, L.L.C. (“Kohlberg”), a private equity firm specializing in middle market investing, announced the...
You must be a Standard 1 Year member to access this content.
